COST-EFFECTIVENESS ANALYSIS OF DONEPEZIL AND RIVASTIGMINE FOR MILD TO MODERATE ALZHEIMER'S DISEASE IN TAIWAN

被引：1
|
作者：
Chen, T. S. [1 ]
Lang, H. C. [1 ]
机构：
[1] Natl Yang Ming Univ, Taipei 112, Taiwan
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.493
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [41] Donepezil for the treatment of mild to moderate Alzheimer's disease in France: The economic implications
    Fagnani, F
    Lafuma, A
    Pechevis, M
    Rigaud, AS
    Traykov, L
    Seux, ML
    Forette, F
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 5 - 13
  • [42] Modeling the Cost-Effectiveness of Galantamine for Mild to Moderately Severe Alzheimer's Disease in Korea
    Suh, Guk-Hee
    [J]. VALUE IN HEALTH, 2009, 12 : S49 - S54
  • [43] Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer's Disease
    Farlow, Martin R.
    Cummings, Jeffrey L.
    Olin, Jason T.
    Meng, Xiangyi
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (04): : 347 - 352
  • [44] Health utilities in Alzheimer’s disease and implications for cost-effectiveness analysis
    Peter J. Neumann
    [J]. PharmacoEconomics, 2005, 23 : 537 - 541
  • [45] An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer’s Disease
    Jan J.V. Busschbach
    Werner B.F. Brouwer
    Adrianus van der Donk
    Jan Passchier
    Frans F.H. Rutten
    [J]. PharmacoEconomics, 1998, 13 : 21 - 34
  • [46] An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease
    Busschbach, JJV
    Brouwer, WBF
    van der Donk, A
    Passchier, J
    Rutten, FFH
    [J]. PHARMACOECONOMICS, 1998, 13 (01) : 21 - 34
  • [47] Health utilities in Alzheimer's disease and implications for cost-effectiveness analysis
    Neumann, PJ
    [J]. PHARMACOECONOMICS, 2005, 23 (06) : 537 - 541
  • [48] Safety and effectiveness of galantamine for mild to moderate Alzheimer's disease
    Alvarez, F. J.
    Blesa, R.
    Ezpeleta, D.
    Romo, I.
    Garcia-Ribas, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 73 - 73
  • [49] Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer’s DiseaseA UK Evaluation Using Discrete-Event Simulation
    Denis Getsios
    Steve Blume
    K. Jack Ishak
    Grant D. H. Maclaine
    [J]. PharmacoEconomics, 2010, 28 : 411 - 427
  • [50] Donepezil and very mild Alzheimer's disease
    不详
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2010, 14 (01) : 30 - 30
12345